-

Robert Stone Recognized as a Top Healthcare CEO in 2025

City of Hope’s CEO was included in both Modern Healthcare’s 100 Most Influential People in Healthcare and Becker’s Hospital Review’s 61 CEO Influencers to Know list

LOS ANGELES--(BUSINESS WIRE)--City of Hope® CEO Robert Stone, who leads one of the largest and most advanced cancer research and treatment organizations in the United States, has been recognized as one of the most influential leaders by two top health care trade publications: Modern Healthcare and Becker’s Hospital Review. Stone was honored for expanding access to advanced cancer care nationwide, advancing breakthrough cancer research, and developing a national network of lifesaving clinical trials, and advocating for more equitable cancer care, among other accomplishments.

Modern Healthcare’s 100 Most Influential People in Healthcare recognizes individuals who are shaping the future of healthcare through visionary leadership and industry-wide impact. Becker’s Hospital Review’s annual list of CEO Influencers to Know highlights chief executives who are driving transformation and influencing the direction of the healthcare industry. This marks the second consecutive year Stone has been included on Modern Healthcare’s list.

“It’s an honor to be recognized among so many visionary leaders who are transforming health care for the people who need us,” said Stone, chief executive officer and the Helen and Morgan Chu Chief Executive Officer Distinguished Chair at City of Hope. “This recognition represents the dedication of our more than 14,000 City of Hope employees who each day live out our values, advance our mission and change the lives of people with cancer. Our patients are the reason all of us at City of Hope continue to accelerate cancer treatment and discoveries.”

Amid a time of rapid innovation coupled with widening gaps in access to lifesaving research and care, City of Hope has transformed into a national organization that delivers cancer breakthroughs to patients across the country. Under Stone’s leadership, the organization has expanded beyond Los Angeles into Atlanta, Chicago, Phoenix and Orange County, Calif.; launched a groundbreaking national clinical trials network designed to make emerging treatments available more quickly at multiple care sites; and accelerated the development of advanced treatments, including immunotherapy and CAR-T, that can dramatically improve outcomes while being delivered closer to where patients live.

Stone has also emphasized a commitment to prioritizing patient survival, experience, and equitable access through policy changes. City of Hope has championed innovative reforms such as the California Cancer Care Equity Act and the Cancer Care is Different coalition, which aim to ensure vulnerable populations and Medicare Advantage seniors can access specialty oncology care.

A strong advocate for workforce development and culture, Stone has also championed talent retention, inclusion, and the cultivation of next-generation professionals, helping to build a diverse and resilient community of 2,000 leading physician-scientists and 14,000 health care professionals.

The complete Modern Healthcare ranking appears in the December issue of the magazine, with profiles of all honorees available online at https://www.modernhealthcare.com/100MostInfluential. Becker’s Hospital Review’s full list of CEO influencers to know, featuring individual profiles, can be found at: https://www.beckershospitalreview.com/hospital-management-administration/61-ceo-influencers-to-know-2025/.

About City of Hope

City of Hope's mission is to make hope a reality for all touched by cancer and diabetes. Founded in 1913, City of Hope has grown into one of the largest and most advanced cancer research and treatment organizations in the United States, and one of the leading research centers for diabetes and other life-threatening illnesses. City of Hope research has been the basis for numerous breakthrough cancer medicines, as well as human synthetic insulin and monoclonal antibodies. With an independent, National Cancer Institute-designated comprehensive cancer center that is ranked among the nation’s top cancer centers by U.S. News & World Report at its core, City of Hope’s uniquely integrated model spans cancer care, research and development, academics and training, and a broad philanthropy program that powers its work. City of Hope’s growing national system includes its Los Angeles campus, Orange County, California, campus, a network of clinical care locations across Southern California and cancer treatment centers and outpatient facilities in the Atlanta, Chicago and Phoenix areas. City of Hope’s affiliated group of organizations includes Translational Genomics Research Institute and AccessHope. For more information about City of Hope, follow us on Facebook, X, YouTube, Instagram and LinkedIn.

Contacts

Samantha Paz
609-658-3290
sapaz@coh.org

City of Hope


Release Versions

Contacts

Samantha Paz
609-658-3290
sapaz@coh.org

More News From City of Hope

Study Reveals How Gut Bacteria and Diet Can Reprogram Fat to Burn More Energy

LOS ANGELES--(BUSINESS WIRE)--Scientists at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S. and a leading research center for diabetes, the Broad Institute and Keio University have discovered how specific gut bacteria work together with diet to flip a metabolic switch — transforming energy‑storing white fat into calorie‑burning beige fat in mice. The study, published today in Nature, shows that a low‑protein diet activates a precise se...

City of Hope®: Early Diagnostics Will Stem the Surge of Colorectal Cancer in Younger Adults

LOS ANGELES--(BUSINESS WIRE)--Experts at City of Hope, one of the nation’s largest and most advanced cancer research and treatment organizations, say the surge in colorectal cancer in people under 50 — often compounded by delayed diagnoses and misinterpreted symptoms — requires age-specific research, treatments, education, and diagnostic tools. A blood test under development at City of Hope could become a breakthrough for detecting the disease early, making it part of an annual exam. Colorectal...

Second Annual $1 Million Stephenson Global Prize Now Open for Nominations

LOS ANGELES--(BUSINESS WIRE)--The Stephenson Global Prize, a $1 million award for innovation in pancreatic cancer research, has opened its second call for nominations. Awarded annually, the Prize recognizes visionary scientific leaders whose work is fundamentally changing the trajectory of pancreatic cancer research. Nominations are now open through May 1, 2026. The Stephenson Global Prize is part of a philanthropic program launched by A. Emmet Stephenson Jr., and Tessa Stephenson Brand. Their...
Back to Newsroom